George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 81.50
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Management Statement

17 Aug 2018 08:25

RNS Number : 1317Y
British Smaller Companies VCT PLC
17 August 2018
 

 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 30 June 2018

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 30 June 2018. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company has continued to make progress with total return rising from 216.0 pence per ordinary share to 217.6 pence per ordinary share in the quarter. This is an increase of 1.6 pence per ordinary share.

It is pleasing that improved performance across a number of investments contributed to the £1.7 million increase in net asset value ("NAV") from the portfolio in the period.

The Company made two new investments of £3.1 million in the quarter, and on 18 May 2018 paid an interim dividend of 4.0 pence per ordinary share.

Performance

The movement in NAV per ordinary share and the dividends paid are set out in the table below:

 

 

 

£m

Pence per

ordinary share

NAV at 1 April 2018

86.1

79.6

Net underlying increase in portfolio

1.7

1.5

Net profit after expenses

0.1

0.1

Issue of shares (DRIS)

1.2

-

Increase in Total Return

3.0

1.6

NAV before the payment of dividends

89.1

81.2

Dividends paid

(4.3)

(4.0)

NAV at 30 June 2018

84.8

77.2

 

30 June 2018

Movement

31 March 2018

Net Assets (£m)

84.8

(1.3)

86.1

NAV per share (PPS)

77.2p

(2.4p)

79.6p

Cumulative dividends paid (PPS)

140.4p

4.0p

136.4p

Total Return (PPS)

217.6p

1.6p

216.0p

Shares in issue

109,941,911

1,751,747

108,190,164

 

The total return at 30 June 2018, calculated by reference to the NAV per ordinary share and the cumulative dividends paid per ordinary share, was 217.6 pence per ordinary share compared to 216.0 pence per ordinary share at 31 March 2018. As a result of the payment of the annual dividend in the quarter, cumulative dividends paid increased by 4.0 pence per ordinary share to 140.4 pence per ordinary share (31 March 2018: 136.4 pence per ordinary share).

The unaudited NAV per ordinary share as at 30 June 2018 was 77.2 pence per ordinary share (31 March 2018: 79.6p pence per ordinary share) representing an increase of 1.6p pence per ordinary share prior to the payment of the dividend of 4.0 pence per ordinary share on 18 May 2018, primarily from the net upward movement in the overall portfolio valuation.

Shares in issue

Pursuant to its dividend re-investment scheme on 18 May 2018 the Company issued 1,751,747 ordinary shares at a price of 70.68 pence per ordinary share.

The number of ordinary shares in issue at 30 June 2018 was 109,941,911 (31 March 2018: 108,190,164). In addition, at 30 June 2018 the Company held 5,225,018 ordinary shares in treasury (31 March 2018: 5,225,018).

On 4 July 2018 the Company purchased 620,767 ordinary shares of 10 pence each at a price of 72.32 pence per ordinary share. These shares were placed in treasury.

Net assets

Net assets at 30 June 2018 comprised the following:

£000

% of net assets

Unquoted investments at fair value

62,878

74.2

Quoted investments at bid price

2,567

3.0

Total investments

65,445

77.2

Fixed income Government security

705

0.8

Listed investment funds

2,378

2.8

Cash and cash equivalents

14,805

17.4

Other net current assets

1,488

1.8

Net assets

84,821

100.0

 

The investment portfolio at 30 June 2018 was comprised as follows:

Valuation

£000

Valuation as a % of net assets

Matillion Limited

5,501

6.5

ACC Aviation

5,426

6.4

Intelligent Office UK

4,492

5.3

Mangar Health Limited

4,382

5.2

Deep-Secure Limited

3,577

4.2

Business Collaborator Limited

3,007

3.6

Eikon Holdco Limited

3,000

3.5

GTK (Holdco) Limited

2,955

3.5

Springboard Research Holdings Limited

2,824

3.3

Gill Marine Holdings Limited

2,744

3.2

37,908

44.7

Other investments

27,537

32.5

Total investments

65,445

77.2

 

During the quarter to 30 June 2018 the Company made two new investments of £3.1 million into Hutchinson Networks Limited (a leading provider of multi-vendor IT and network solutions to clients globally) and Arcus Global Limited (a provider of cloud-based software solutions to local and national public sector organisations).

In the quarter to 30 June 2018 the realisation and repayment of investments and loans generated cash proceeds of £2.0 million.

Portfolio Performance

Over the quarter to 30 June 2018 the aggregate portfolio valuation has increased by £1.7 million.

The Board continues to follow its policy of maintaining a diversified portfolio. At 30 June 2018, four investments represented more than 5 per cent of the Company's NAV, the largest being 6.5 per cent.

Fundraising

Having reviewed the Company's likely funding requirements, the Board is considering a full-prospectus fundraising during the current tax year. The quantum and mechanism of the fundraising will be communicated nearer to the launch.

Outlook

The European Commission has approved the revised VCT rules, which means that VCTs are now able to invest up to £10 million into knowledge intensive businesses in any 12-month period. Your Board welcomes this change and, despite the lack of clarity on the UK's future trading relationship with the rest of the EU, these rule changes will allow VCTs to make larger investments in qualifying businesses.

HMRC's advance assurance process now seems to be improving and this has helped to deliver an encouraging level of investment in the first 3 months of the financial year, continuing the trend seen in the previous 3 months. Investments made under the new rules now comprise 31 per cent of the unquoted portfolio and it is pleasing that two well-known specialist US venture investors have recognised the strength of our investee company Matillion's potential through a significant recent investment.

Many of the more mature investments in the portfolio continue to deliver good returns and opportunities to realise them at attractive valuations are constantly evaluated.

Your Board remains highly selective when making investments, although investing in earlier stage companies will increase the risk profile of the portfolio. We hope that shareholders will take advantage of the planned fundraising to increase their investment in the Company.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

17 August 2018

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Jonathan Becher Panmure Gordon (UK) Limited Tel: 0207 886 2715

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
QRFEAXPXFEAPEEF
Date   Source Headline
3rd Apr 20247:58 amRNSIssue of Equity and Close of Offers
26th Mar 202411:11 amRNSTransaction in Own Shares and Total Voting Rights
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
20th Mar 202412:00 pmRNSPublication of Supplementary Prospectus
15th Mar 202412:15 pmRNS3rd Quarter Results
16th Feb 20243:52 pmRNSClose of Offers to New Applications
16th Feb 20243:51 pmRNSClose of Offers to New Applications
30th Jan 20249:23 amRNSIssue of Equity
18th Dec 20234:02 pmRNSTransaction in Own Shares
13th Dec 20234:00 pmRNSOffer Update
13th Dec 20234:00 pmRNSStrategy/Company/Ops Update
8th Dec 20239:47 amRNSPayment of Dividend and Issue of Equity
24th Nov 20237:00 amRNSHalf-year Report
26th Oct 20231:34 pmRNSDividend Declaration
24th Oct 20231:20 pmRNSOffer Update
24th Oct 20231:19 pmRNSOffer Update
6th Oct 202310:19 amRNSOffer Update
6th Oct 202310:17 amRNSOffer Update
27th Sep 20238:21 amRNSOffer Update
26th Sep 20238:20 amRNSTransaction in Own Shares and PDMR
20th Sep 202312:30 pmRNSPublication of a Prospectus
20th Sep 202312:30 pmRNSPublication of a Prospectus
14th Sep 202310:28 amRNSResult of AGM
14th Sep 202310:28 amRNSResult of General Meeting
13th Sep 20237:00 amRNS1st Quarter Results
2nd Aug 202310:25 amRNSNew combined offer for subscription
2nd Aug 202310:25 amRNSNew combined offer for subscription
28th Jul 202310:00 amRNSDirector/PDMR Shareholding
28th Jul 202310:00 amRNSPayment of Dividend and Issue of Equity
27th Jun 20237:45 amRNSTransaction in Own Shares
21st Jun 20231:00 pmRNSPublication of Circular
16th Jun 202312:00 pmRNSAnnual Financial Report
4th Apr 20233:24 pmRNSDirector/PDMR Shareholding
4th Apr 20233:23 pmRNSIssue of Equity and Close of Offers
29th Mar 20238:42 amRNSTransaction in Own Shares
27th Mar 20236:00 pmRNSClose of Offers to new Applications
27th Mar 20236:00 pmRNSClose of Offers to new Applications
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
22nd Mar 202312:15 pmRNSPublication of Supplementary Prospectus
20th Mar 20233:00 pmRNS3rd Quarter Results
14th Feb 20234:35 pmRNSOffer Update
14th Feb 20234:35 pmRNSOffer Update
11th Jan 202310:00 amRNSDirector/PDMR Shareholding
11th Jan 202310:00 amRNSPayment of Dividend and Issue of Equity
19th Dec 20228:48 amRNSTransaction in Own Shares
6th Dec 20229:58 amRNSOffer Update
6th Dec 20229:58 amRNSOffer Update
30th Nov 202212:30 pmRNSPublication of a Prospectus
30th Nov 202212:30 pmRNSPublication of a Prospectus
25th Nov 20229:30 amRNSHalf-year Report

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.